GLPwatch

Danuglutide vs Dulaglutide

Molecule comparison

Last updated 2026-05-28 15:46 UTC

Danuglutide is an experimental GLP-1 drug still in development, while dulaglutide (sold as Trulicity) is an FDA-approved GLP-1 treatment. Dulaglutide is approved for type 2 diabetes and reducing cardiovascular risk, whereas danuglutide has no approved uses yet. Both work the same way by acting as GLP-1 receptor agonists, but dulaglutide is already on the market as a once-weekly injection.

AI summary of the sources below.

Danuglutide Dulaglutide
MechanismGLP-1 receptor agonistGLP-1 receptor agonist
StatusPipelineApproved
Branded productstrulicity

Compare full details on the Danuglutide and Dulaglutide pages.